AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $21,618,000 | -56.0% | 598,830 | -25.0% | 0.61% | -37.6% |
| Q3 2018 | $49,140,000 | -6.0% | 798,376 | +3.1% | 0.98% | -9.1% |
| Q2 2018 | $52,296,000 | +52.8% | 774,180 | +22.7% | 1.08% | +55.3% |
| Q1 2018 | $34,234,000 | -3.4% | 631,047 | +6.4% | 0.70% | +3.3% |
| Q4 2017 | $35,437,000 | +40.3% | 593,086 | +14.1% | 0.67% | +56.5% |
| Q3 2017 | $25,263,000 | +30.4% | 519,806 | +41.0% | 0.43% | +34.4% |
| Q2 2017 | $19,374,000 | +51.3% | 368,673 | +30.6% | 0.32% | +77.8% |
| Q1 2017 | $12,803,000 | +44.8% | 282,309 | +20.8% | 0.18% | +56.5% |
| Q4 2016 | $8,843,000 | -26.4% | 233,620 | -26.6% | 0.12% | -11.5% |
| Q3 2016 | $12,013,000 | +808.0% | 318,311 | +323.6% | 0.13% | +900.0% |
| Q2 2016 | $1,323,000 | -22.5% | 75,146 | -46.5% | 0.01% | -13.3% |
| Q1 2016 | $1,708,000 | +12.3% | 140,420 | +124.8% | 0.02% | +25.0% |
| Q4 2015 | $1,521,000 | +13.2% | 62,457 | -17.6% | 0.01% | +9.1% |
| Q3 2015 | $1,344,000 | -79.1% | 75,756 | -79.2% | 0.01% | -75.6% |
| Q2 2015 | $6,431,000 | +275.2% | 364,379 | +566.1% | 0.04% | +275.0% |
| Q1 2015 | $1,714,000 | -31.7% | 54,705 | -36.3% | 0.01% | -33.3% |
| Q4 2014 | $2,508,000 | +0.5% | 85,932 | -28.8% | 0.02% | 0.0% |
| Q3 2014 | $2,496,000 | +109.7% | 120,617 | +151.1% | 0.02% | +125.0% |
| Q2 2014 | $1,190,000 | +6.7% | 48,029 | -8.7% | 0.01% | +14.3% |
| Q1 2014 | $1,115,000 | – | 52,634 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|